BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 552041)

  • 1. Bis(2-ethylhexyl) phthalate levels in nonuremic patients treated with extracorporeal devices.
    Chen WS; Kerkay J; Pearson KH; Paganini EP; Chang K; Steck WD; Becker JM; Bailin PL; Nakamoto S
    Proc Clin Dial Transplant Forum; 1979; 9():189-93. PubMed ID: 552041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of plasticiser from haemodialysis blood tubing.
    Ono K; Ikeda T; Fukumitsu T; Tatsukawa R; Wakimoto T
    Proc Eur Dial Transplant Assoc; 1976; 12():571-6. PubMed ID: 935139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis.
    Gibson TP; Briggs WA; Boone BJ
    J Lab Clin Med; 1976 Mar; 87(3):519-24. PubMed ID: 1249479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the di-2-ethylhexyl phthalate (DEHP) in blood preparations preserved in polyvinyl chloride bags].
    Pick G; Brainer G; Kálmánné Z; Józsefné P
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):49-51. PubMed ID: 424402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemical studies on compatibility to medical application III. Prevention of migration of DEHP from blood tubings].
    Tsuji K; Shintani H; Kikuchi H; Oba T; Wada Y
    Eisei Shikenjo Hokoku; 1984; (102):45-8. PubMed ID: 6532508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Di-2-ethylhexyl phthalate (DEHP) in blood preparations stored in PVC bags].
    Pick J; Breuer HJ; Zsdánszky K; Pintér J
    Acta Pharm Hung; 1978 Sep; 48(5):230-5. PubMed ID: 707118
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood circuits during hemodialysis and pump-oxygenation therapy.
    Haishima Y; Matsuda R; Hayashi Y; Hasegawa C; Yagami T; Tsuchiya T
    Int J Pharm; 2004 Apr; 274(1-2):119-29. PubMed ID: 15072788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phthalic acid is the main metabolite of the plasticizer di(2-ethylhexyl) phthalate in peritoneal dialysis patients.
    Mettang T; Alscher DM; Pauli-Magnus C; Dunst R; Kuhlmann U; Rettenmeier AW
    Adv Perit Dial; 1999; 15():229-33. PubMed ID: 10682108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of the quality control of synthetic polymers used in hematology].
    Nowicki P; Kłos M
    Polim Med; 1983; 13(3-4):125-42. PubMed ID: 6680177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis.
    Nässberger L; Arbin A; Ostelius J
    Nephron; 1987; 45(4):286-90. PubMed ID: 3587468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients.
    Lewis LM; Flechtner TW; Kerkay J; Pearson KH; Nakamoto S
    Clin Chem; 1978 May; 24(5):741-6. PubMed ID: 647906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
    Koch HM; Bolt HM; Preuss R; Angerer J
    Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of phthalic acid, mono-(2-ethylhexyl) phthalate and di-(2-ethylhexyl) phthalate in human plasma and in blood products.
    Shintani H
    J Chromatogr; 1985 Feb; 337(2):279-90. PubMed ID: 3988859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for a new plasticizer for polyvinyl chloride medical devices.
    Kevy SV; Jacobson MS; Harmon WE
    Trans Am Soc Artif Intern Organs; 1981; 27():386-90. PubMed ID: 7331098
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis.
    Pollack GM; Buchanan JF; Slaughter RL; Kohli RK; Shen DD
    Toxicol Appl Pharmacol; 1985 Jun; 79(2):257-67. PubMed ID: 4002227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased accumulation of phthalate plasticizer during storage of blood as packed cells.
    Miripol JE; Stern IJ
    Transfusion; 1977; 17(1):71-3. PubMed ID: 841679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic phthalate exposure on the kidney.
    Crocker JF; Safe SH; Acott P
    J Toxicol Environ Health; 1988; 23(4):433-44. PubMed ID: 3361614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipidic fractions from human serum polluted by phthalate esters (author's transl)].
    Lagente M; de La Farge F; de Graeve J; Valdiguie P
    Nouv Presse Med; 1979 Feb; 8(8):610. PubMed ID: 461176
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of membrane Na(+)-K+ Atpase of the brain, liver and RBC in rats administered di(2-ethyl hexyl) phthalate (DEHP) a plasticizer used in polyvinyl chloride (PVC) blood storage bags.
    Dhanya CR; Indu AR; Deepadevi KV; Kurup PA
    Indian J Exp Biol; 2003 Aug; 41(8):814-20. PubMed ID: 15248477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans.
    Silva MJ; Samandar E; Preau JL; Needham LL; Calafat AM
    Toxicology; 2006 Feb; 219(1-3):22-32. PubMed ID: 16332407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.